​Dr. Paul C. Guest, Ph.D, is a scientific researcher/writer with 37 years of experience in the fields of metabolic and neurological disorders. This includes experience in both academia and the pharmaceutical industry with the majority of time spent at the University of Cambridge and Merck Sharp & Dohme in the United Kingdom. He has also been affiliated with the University of Campinas in Sao Paulo Brazil since 2015, still focused on advancing the field of biomarkers for neurological disorders such as schizophrenia and Alzheimer’s disease, and more recently in the area of anti-aging research.

• New Therapeutic Approaches and Biomarkers for Increased Healthspan.- Targeting Cancer Metabolism and Current Anti-Cancer Drugs.- A Review of Monoclonal Antibody-based Treatments in Non-small Cell Lung Cancer.- Parkinson’s Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature.- Targeted Treatment of Age-related Fibromyalgia with Supplemental Coenzyme Q10.- Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.- Multifaceted Roles of Long Non-coding RNAs in Head and Neck Cancer.- A Systematic Review on the Genotoxic Effects of Selective Serotonin Reuptake Inhibitors.- Towards a New Era for the Management of Circulating Tumor Cells.- Telomerase: A target for Therapeutic Effects of Curcumin in Cancer.- Aspirin as a Potential Geroprotector: Experimental Data and Clinical Evidence.- Targeting Stem Cells in Chronic Inflammatory Diseases.- Therapeutic Strategies and Nano-drug Delivery Applications in Management of Aging Alzheimer's Disease.- Psychometric Evaluation of Stress in 17,414 Critical Care Unit Nurses: Effects of Age, Gender and Working Conditions.- Targeting Age-related Neurodegenerative Diseases by AAV Mediated Gene Therapy.- Is Adipose Tissue the Fountain of Youth? The impact of Adipose Atem Cell Aging on Metabolic Homeostasis, Longevity and Cell-Based Therapies.- Proteomics for Target Identification in Psychiatric and Neurodegenerative Disorders.- Index.

​Dr. Paul C. Guest, Ph.D, is a scientific researcher/writer with 37 years of experience in the fields of metabolic and neurological disorders. This includes experience in both academia and the pharmaceutical industry with the majority of time spent at the University of Cambridge and Merck Sharp & Dohme in the United Kingdom. He has also been affiliated with the University of Campinas in Sao Paulo Brazil since 2015, still focused on advancing the field of biomarkers for neurological disorders such as schizophrenia and Alzheimer’s disease, and more recently in the area of anti-aging research.

• New Therapeutic Approaches and Biomarkers for Increased Healthspan.- Targeting Cancer Metabolism and Current Anti-Cancer Drugs.- A Review of Monoclonal Antibody-based Treatments in Non-small Cell Lung Cancer.- Parkinson’s Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature.- Targeted Treatment of Age-related Fibromyalgia with Supplemental Coenzyme Q10.- Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.- Multifaceted Roles of Long Non-coding RNAs in Head and Neck Cancer.- A Systematic Review on the Genotoxic Effects of Selective Serotonin Reuptake Inhibitors.- Towards a New Era for the Management of Circulating Tumor Cells.- Telomerase: A target for Therapeutic Effects of Curcumin in Cancer.- Aspirin as a Potential Geroprotector: Experimental Data and Clinical Evidence.- Targeting Stem Cells in Chronic Inflammatory Diseases.- Therapeutic Strategies and Nano-drug Delivery Applications in Management of Aging Alzheimer's Disease.- Psychometric Evaluation of Stress in 17,414 Critical Care Unit Nurses: Effects of Age, Gender and Working Conditions.- Targeting Age-related Neurodegenerative Diseases by AAV Mediated Gene Therapy.- Is Adipose Tissue the Fountain of Youth? The impact of Adipose Atem Cell Aging on Metabolic Homeostasis, Longevity and Cell-Based Therapies.- Proteomics for Target Identification in Psychiatric and Neurodegenerative Disorders.- Index.